These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28290666)

  • 1. Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.
    Shi NQ; Qi XR
    ACS Appl Mater Interfaces; 2017 Mar; 9(12):10519-10529. PubMed ID: 28290666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
    ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
    Shi NQ; Gao W; Xiang B; Qi XR
    Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
    Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
    Dragojevic S; Mackey R; Raucher D
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
    Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
    Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.
    Huang Y; Jiang Y; Wang H; Wang J; Shin MC; Byun Y; He H; Liang Y; Yang VC
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1299-315. PubMed ID: 23369828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
    Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
    ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
    Ye J; Shin MC; Liang Q; He H; Yang VC
    J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy.
    Yoo J; Sanoj Rejinold N; Lee D; Jon S; Kim YC
    J Control Release; 2017 Oct; 264():89-101. PubMed ID: 28842316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery.
    Cheng H; Zhu JY; Xu XD; Qiu WX; Lei Q; Han K; Cheng YJ; Zhang XZ
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):16061-9. PubMed ID: 26161578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.
    Yang Y; Yang Y; Xie X; Cai X; Mei X
    J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
    Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
    Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.